Nordic Capital makes a bid to purchase Advanz Pharma in $846 mn deal
Under the offer, shareholders would receive a price of $17.26 per Advanz Pharma share
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
pharma deal
Hikma intends to acquire assets in Egypt, Tunisia
Further talks with GSK will depend on the results of its due-diligence process
Angelini Pharma acquires Arvelle Therapeutics for $960 million
Angelini Pharma will have the exclusive license to commercialise cenobamate in the European Union and other countries in the…
Recipharm, Moderna sign deal for manufacturing, fill-finish of COVID-19 vaccines
They have reached an agreement to support formulation and fill-finish a part of the Moderna COVID-19 vaccine supply outside of the…
ImmunityBio and NantKwest announce merger
Merged entity brings together 11 Phase II / III clinical trials across oncology and infectious disease that use combined…
EQT makes $2.8 bn bid for Recipharm
EQT said it was bidding 220 crowns per Recipharm share, a 22.9 per cent premium to Recipharm’s closing price
Sanofi invests 50 million euros in Jeito Capital
The investment will be deployed by Jeito’s team, in line with its investment criteria, to support French and European healthcare…
Deal value in the M&A market decreased in Sept 2020 compared to $35.7 bn in Aug 2020
In September 2020, the healthcare industry reported 84 deals worth $28.2 billion as compared to the last 12-month average…
Sanofi concludes acquisition of Principia Biopharma
The Principia acquisition strengthens Sanofi’s core areas of autoimmune and allergic diseases
Takeda sells select non-core assets in Europe to Cheplapharm for about $562 mn
Portfolio includes prescription products in Takeda’s cardiovascular/metabolic and anti-inflammatory therapeutic areas along with…